tirzepatide glp 1 agonist Diabetes Patients Also Struggle to Access GLP-1 Agonists Beyond GLP-1: New 5-In-1 Compound

The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, then set dates after which compounders could no longer produce preparations that are essentially copies of the approved products February 18, 2025 for 503A pharmacies on tirzepatide and April 22, 2025 for 503A pharmacies on semaglutide

The states they currently do not ship to include AR, IN, MN, SC and TX (Texas requires doctors to have TX license)

These numbers include water from food, but semaglutide users who eat less food get less water from dietary sources

With the novel coronavirus gripping a large number of kids in this wave, doctors fear a bigger re-run of MIS-C which they saw in the previous pandemic wave too

it does not replace it

The headspace between the liquid surface and the stopper